Bailard, Inc. Sage Therapeutics, Inc. Transaction History

Bailard, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$58.41 - $89.06 $262,845 - $400,770	-4,500 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$41.13 - $62.45 $185,085 - $281,025	4,500 New	4,500 $275,000
Q4 2019 Jan 31, 2020	SELL	$60.18 - $154.77 $102,306 - $263,109	-1,700 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$89.33 - $163.65 $151,861 - $278,205	1,700 New	1,700 $270,000
Q4 2018 Feb 05, 2019	SELL	$81.94 - $139.71 $139,298 - $237,507	-1,700 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$60.72 - $167.34 $103,224 - $284,478	1,700	1,700 $0

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $284M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.